CREAD · BN29552
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy and safety of crenezumab in patients with prodromal to mild Alzheimer’s disease. EudraCT: 2015-003034-27.
Sponsor: ROCHE
Phase: III
Area: Cognitive disorders